Published in J Neuroendocrinol on July 01, 2011
Diagnosis and complications of Cushing's syndrome: a consensus statement. J Clin Endocrinol Metab (2003) 3.33
PI3KCA/PTEN deregulation contributes to impaired responses to cetuximab in metastatic colorectal cancer patients. Ann Oncol (2008) 2.75
Immunoradiometric versus enzymatic renin assay: results of the Italian Multicenter Comparative Study. Italian Multicenter Study for Standardization of Renin Measurement. J Hypertens (1995) 2.44
The brown colour effect (BCE) of Cryptococcus neoformans in the diagnosis, control and epidemiology of C. neoformans infections in AIDS patients. Zentralbl Bakteriol Mikrobiol Hyg A (1987) 2.31
Factors influencing the immediate and late outcome of Cushing's disease treated by transsphenoidal surgery: a retrospective study by the European Cushing's Disease Survey Group. J Clin Endocrinol Metab (1995) 2.00
AME position statement on adrenal incidentaloma. Eur J Endocrinol (2011) 1.82
The role of breast FNAC in diagnosis and clinical management: a survey of current practice. Cytopathology (2008) 1.75
Acromegaly associated with a granular cell tumor of the neurohypophysis: a clinical and histological study. Case report. J Neurosurg (2000) 1.60
Comprehensive critical incident monitoring in a neonatal-pediatric intensive care unit: experience with the system approach. Intensive Care Med (2000) 1.58
First-line therapy of acromegaly: a statement of the A.L.I.C.E. (Acromegaly primary medical treatment Learning and Improvement with Continuous Medical Education) Study Group. J Endocrinol Invest (2006) 1.52
New once-daily, highly effective rescue triple therapy after multiple Helicobacter pylori treatment failures: a pilot study. Aliment Pharmacol Ther (2005) 1.50
Primary metastatic (stage IV) Ewing tumor: survival analysis of 171 patients from the EICESS studies. European Intergroup Cooperative Ewing Sarcoma Studies. Ann Oncol (1998) 1.47
Enhanced expression of transforming growth factor beta1 in rat thyroid hyperplasia is thyrotropin induced and time dependent. Eur J Endocrinol (1996) 1.41
Nested polymerase chain reaction for diagnosis and monitoring treatment response in AIDS patients with tuberculous meningitis. AIDS (1995) 1.37
Cardiac involvement in Becker muscular dystrophy. J Am Coll Cardiol (1993) 1.36
Incidentally discovered adrenal tumors: endocrine and scintigraphic correlates. J Clin Endocrinol Metab (1998) 1.34
Cetuximab in recurrent and/or metastatic salivary gland carcinomas: A phase II study. Oral Oncol (2008) 1.31
Cardiovascular risk factors in primary care: methods and baseline prevalence rates--the DETECT program. Curr Med Res Opin (2005) 1.29
Urinary free cortisone and the assessment of 11 beta-hydroxysteroid dehydrogenase activity in man. Clin Endocrinol (Oxf) (1996) 1.23
Cerebrospinal fluid HIV-1 RNA levels: correlation with HIV encephalitis. AIDS (1998) 1.19
Efficient decoy-state quantum key distribution with quantified security. Opt Express (2013) 1.19
Diagnostic terminology for reporting thyroid fine needle aspiration cytology: European Federation of Cytology Societies thyroid working party symposium, Lisbon 2009. Cytopathology (2010) 1.19
Purification of recombinant antigenic epitopes of the human 68-kDa (U1) ribonucleoprotein antigen using the expression system pH6EX3 followed by metal chelating affinity chromatography. Protein Expr Purif (1992) 1.19
RET/PTC activation in hyalinizing trabecular tumors of the thyroid. Am J Surg Pathol (2000) 1.17
A 3' consensus splice mutation in the human dystrophin gene detected by a screening for intra-exonic deletions. Hum Mol Genet (1992) 1.17
Ewing's tumors with primary lung metastases: survival analysis of 114 (European Intergroup) Cooperative Ewing's Sarcoma Studies patients. J Clin Oncol (1998) 1.14
Evaluation of health-related quality of life in patients with Cushing's syndrome with a new questionnaire. Eur J Endocrinol (2008) 1.14
Macrophage-secreted myogenic factors: a promising tool for greatly enhancing the proliferative capacity of myoblasts in vitro and in vivo. Neurol Sci (2002) 1.12
Primary angiitis of the central nervous system: serial MRI of brain and spinal cord. Neuroradiology (2001) 1.12
Expression of epidermal growth factor receptor in neoplastic pituitary cells: evidence for a role in corticotropinoma cells. J Endocrinol (2004) 1.08
Prevalence of dystrophin-positive fibers in 85 Duchenne muscular dystrophy patients. Neuromuscul Disord (1992) 1.07
Consensus guidelines on screening for hypopituitarism following traumatic brain injury. Brain Inj (2005) 1.05
Risk factors for thyroid cancer in northern Italy. Int J Epidemiol (1989) 1.05
Cloning and expression of antigenic epitopes of the human 68-kDa (U1) ribonucleoprotein antigen in Escherichia coli. Biotechniques (1991) 1.05
Retinoic acid prevents experimental Cushing syndrome. J Clin Invest (2001) 1.05
Proliferation index of nonfunctioning pituitary adenomas: correlations with clinical characteristics and long-term follow-up results. Neurosurgery (2000) 1.05
Ketoconazole treatment in Cushing's syndrome: experience in 34 patients. Clin Endocrinol (Oxf) (1991) 1.04
Complement-fixing adrenal autoantibodies as a marker for predicting onset of idiopathic Addison's disease. Lancet (1983) 1.04
Risk factors and long-term follow-up of adrenal incidentalomas. J Clin Endocrinol Metab (1999) 1.03
The natural history of adrenal function in autoimmune patients with adrenal autoantibodies. J Endocrinol (1988) 1.03
The expression of the antiproliferative gene ZAC is lost or highly reduced in nonfunctioning pituitary adenomas. Cancer Res (2000) 1.02
Dystrophin-positive fibers in Duchenne dystrophy: origin and correlation to clinical course. Muscle Nerve (1995) 1.02
Cardiovascular risk factors and ultrasound evaluation of intima-media thickness at common carotids, carotid bulbs, and femoral and abdominal aorta arteries in patients with classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency. J Clin Endocrinol Metab (2007) 1.01
Comparison of circulating and local adipose tissue renin-angiotensin system in normotensive and hypertensive obese subjects. J Endocrinol Invest (2002) 1.01
CA-Repeat polymorphism in intron 1 of HSD11B2 : effects on gene expression and salt sensitivity. Hypertension (2000) 1.01
Cryptic 21-hydroxylase deficiency in families of patients with classical congenital adrenal hyperplasia. J Clin Endocrinol Metab (1980) 1.00
Delta infection and liver disease in hemophilic carriers of hepatitis B surface antigen. J Infect Dis (1982) 1.00
Adrenocortical cancer treatment. Horm Res (2009) 1.00
Body composition and metabolic features in women with adrenal incidentaloma or Cushing's syndrome. J Clin Endocrinol Metab (2001) 1.00
High intrafamilial variability in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy: a case study. J Endocrinol Invest (2011) 0.99
Solitary fibrous tumour of the thyroid: clinicopathological, immunohistochemical and ultrastructural study of three cases. Virchows Arch A Pathol Anat Histopathol (1993) 0.98
Association of somatotrophinomas with loss of alleles on chromosome 11 and with gsp mutations. J Clin Invest (1993) 0.98
Insulin resistance in Cushing's syndrome. J Clin Endocrinol Metab (1983) 0.98
Proton magnetic resonance spectroscopy and intracranial tumours: clinical perspectives. J Neurol (1996) 0.98
Alterations in ventricular size and intracranial pressure caused by sagittal sinus pathology in man. J Neurosurg (1980) 0.97
Production of recombinant rat interleukin-6 in Escherichia coli using a novel highly efficient expression vector pGEX-3T. Biotechniques (1992) 0.96
Predictors of morbidity and mortality in acromegaly: an Italian survey. Eur J Endocrinol (2012) 0.96
Molecular genetic studies of sporadic pituitary tumors. J Clin Endocrinol Metab (1994) 0.96
Patients with Cushing's syndrome have increased intimal media thickness at different vascular levels: comparison with a population matched for similar cardiovascular risk factors. Horm Metab Res (2006) 0.96
Malignant astrocytoma associated with arteriovenous malformation. Case report. Acta Neurochir (Wien) (1979) 0.95
A case of primary aldosteronism in pregnancy: do LH and GNRH receptors have a potential role in regulating aldosterone secretion? Eur J Endocrinol (2011) 0.95
Efficacy of the new long-acting formulation of lanreotide (lanreotide Autogel) in somatostatin analogue-naive patients with acromegaly. J Endocrinol Invest (2009) 0.95
Decreased nitric oxide levels and increased calcium content in platelets of hypertensive patients. Am J Hypertens (2001) 0.94
A comparison of brain biopsy and CSF-PCR in the diagnosis of CNS lesions in AIDS patients. J Neurol (1997) 0.94
Concurrent spontaneous CSF otorrhea and rhinorrhea. Eur Neurol (1982) 0.94
Genetic and hormonal characterization of cryptic 21-hydroxylase deficiency. J Clin Endocrinol Metab (1981) 0.94
Calmodulin-dependent kinase II mediates vascular smooth muscle cell proliferation and is potentiated by extracellular signal regulated kinase. Endocrinology (2010) 0.93
Primary brain CD30+ ALK1+ anaplastic large cell lymphoma ('ALKoma'): the first case with a combination of 'not common' variants. Ann Oncol (2002) 0.93
Laparoscopic adrenalectomy by the anterior transperitoneal approach: results of 108 operations in unselected cases. Surg Endosc (2000) 0.93
Diet and epithelial cancer of the thyroid gland. Tumori (1990) 0.92
Benign intracranial hypertension without papilledema: case report. Neurosurgery (1979) 0.92
Reactive perivascular T-cell infiltrate predicts survival in primary central nervous system B-cell lymphomas. Br J Haematol (2007) 0.92
Defective fasciculata zone function as the mechanism of glucocorticoid-remediable aldosteronism. J Clin Endocrinol Metab (1990) 0.92
High speed prototype quantum key distribution system and long term field trial. Opt Express (2015) 0.91
Histological and ultrastructural study of intracranial saccular aneurysmal wall. Acta Neurochir (Wien) (1978) 0.91
Morphological quality and nucleic acid preservation in cytopathology. J Clin Pathol (2008) 0.91
Curcumin suppresses HIF1A synthesis and VEGFA release in pituitary adenomas. J Endocrinol (2012) 0.90
Bacterial endotoxin (lipopolysaccharide) stimulates interleukin-6 production and inhibits growth of pituitary tumour cells expressing the toll-like receptor 4. J Neuroendocrinol (2005) 0.90
The desmopressin test in the differential diagnosis between Cushing's disease and pseudo-Cushing states. J Clin Endocrinol Metab (2000) 0.90
Neurogenic hypernatraemia: case report. Acta Neurochir (Wien) (1979) 0.90
Staib agar supplemented with a triple antibiotic combination for the detection of Cryptococcus neoformans in clinical specimens. Mycoses (1989) 0.90
Role of insulin and atrial natriuretic peptide in sodium retention in insulin-treated IDDM patients during isotonic volume expansion. Diabetes (1990) 0.90
Gene expression of angiotensinogen in adipose tissue of obese patients. Int J Obes Relat Metab Disord (2000) 0.90
The protective role of ubiquinol-10 against formation of lipid hydroperoxides in human seminal fluid. Mol Aspects Med (1997) 0.90
Ewing tumour: incidence, prognosis and treatment options. Paediatr Drugs (2001) 0.90
The tissue renin-angiotensin system in rats with fructose-induced hypertension: overexpression of type 1 angiotensin II receptor in adipose tissue. J Hypertens (2000) 0.89
Clinical, histological and ultrastructural observations upon the oncocytoma of the human pituitary gland. J Neurosurg Sci (1976) 0.89
Duchenne phenotype with in-frame deletion removing major portion of dystrophin rod: threshold effect for deletion size? Muscle Nerve (1996) 0.89
Intrinsic haematopoietic activity of cerebellar haemangioblastomas. Ultrastructural study of three cases. Neurochirurgia (Stuttg) (1979) 0.89
Neuromelanin and iron in human locus coeruleus and substantia nigra during aging: consequences for neuronal vulnerability. J Neural Transm (Vienna) (2006) 0.89
Duodenal periampullary gangliocytic paraganglioma: report of two cases with immunohistochemical and ultrastructural study. Ultrastruct Pathol (2001) 0.89
Spironolactone in the treatment of polycystic ovary syndrome: effects on clinical features, insulin sensitivity and lipid profile. J Endocrinol Invest (2005) 0.88